NEWS
May 13 2003, Press release, International Association of Business Leaders

back
Local leader selected as international business leader of the year
 
The International Association of Business Leaders has announced that local business leader, Dr. Ilse Piippo, Vice President of Vaccine Safety and Clinical Development for FIT Biotech, Plc. in Parainen, Finland, was selected recently as the International Association of Business Leaders' 2003 International Business Leader of the Year. Dr. Piippo and the other award winners were recognized at a special banquet held in their honor on 26 April 2003 in Montego Bay, Jamaica during the Association's annual leadership conference.

The IABL Award Committee and the Association's Board of Advisors examined over 10,000 nominees this year for the International Business Leader of the Year, International Entrepreneur of the Year, and International Manager of the Year awards. All nominees were carefully screened for their professional accomplishments, community involvement, personal leadership, communication skills, and business development activities. The award winners for each category represent a unique degree of accomplishment, commitment to improving the lives of all people, and development of future generations of caring leaders.

As the Vice President of Vaccine Safety and Clinical Development for FIT Biotech, Plc., Dr. Piippo oversees the development of vaccines and the corresponding conduction of pre-clinical safety studies and clinical trials. Dr. Piippo facilitates the company's attainment of clinical and regulatory goals and manages formulation development processes. Established in 1998, FIT Biotech, Plc. is an innovative global company with a worldwide research network engaged in the development and commercialization of novel DNA vaccines and diagnostic products for currently unmet clinical needs. Trained as a pharmacist and medical doctor, Dr. Piippo applies her expertise to assuring vaccine safety, quality assurance, and directing outsourcing efforts to meet quality, production, and cost-effective standards. She draws from her superior communication skills and bilingual abilities in Finnish and English to negotiate with third parties and to network with a variety of international partners in the formation of strategic alliances within the region. A significant career achievement, Dr. Piippo conducted the first clinical trials in Finland with DNA plasmid and assisted in founding the first biotechnology company in Finland with Good Manufacturing Practice regulations (GMP) as established by the US Food and Drug Administration. Dr. Piippo, responsible for the registration of four new chemical entities worldwide, was highly involved in related product development from the initial molecular synthesis through marketing stages. Possessing a wealth of pharmaceutical experience coupled with solid business acumen, Dr. Piippo has assisted in strengthening the clinical, quality assurance, and regulatory departments and functions within FIT Biotech, Plc. Looking toward the future, Dr. Piippo plans to develop an HIV vaccine and to build a global clinical, pre-clinical, and formulation network with strategic partners.

The International Association of Business Leaders provides exceptionally qualified businesspersons, such as Dr. Piippo, a unique avenue to improve communications and relations with their peers around the globe. By fostering active communication and understanding between individuals of diverse backgrounds, the Association works to create a more positive atmosphere of cooperation between all cultures and communities around the world. The Association was founded on the core belief that mutual respect and understanding between all nations and cultures develops the opportunity for the new business activities that will improve the lives and future of people everywhere.

Membership in the IABL is only awarded to selected business and professional leaders around the globe who have been identified for their exceptional leadership skills in the increasingly complex world of international business. The membership of the Association represents the very best in the business, professional, education, and scientific communities. Selection as a finalist for the IABL's prestigious awards within a group of such remarkable individuals is a truly notable accomplishment.
 
Further information
 
Ms. Yvonne Guy
International Association of Business Leaders, Inc.
+252-637-6066
yguy@leadersofbusiness.org

back
 
FIT Biotech Oyj Plc. Biokatu 8
33520 Tampere
Finland
Tel.
Fax
+358 3 3138 7000
+358 3 3138 7050
E-mail firstname.lastname@fitbiotech.com
info@fitbiotech.com